Belite Bio, Inc
BLTE
$155.54
$3.572.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 12/31/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | 10.06M | 10.06M | 12.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 40.00M | 40.00M | 43.84M |
| Operating Income | -- | -- | -40.00M | -40.00M | -43.84M |
| Income Before Tax | -- | -- | -36.14M | -36.14M | -42.11M |
| Income Tax Expenses | -- | -- | 6.00K | 6.00K | 6.00K |
| Earnings from Continuing Operations | -- | -- | -36.14 | -36.14 | -42.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -36.14M | -36.14M | -42.12M |
| EBIT | -- | -- | -40.00M | -40.00M | -43.84M |
| EBITDA | -- | -- | -39.84M | -39.84M | -43.72M |
| EPS Basic | -- | -- | -1.18 | -1.18 | -1.41 |
| Normalized Basic EPS | -- | -- | -0.18 | -0.38 | -0.15 |
| EPS Diluted | -- | -- | -1.18 | -1.18 | -1.41 |
| Normalized Diluted EPS | -- | -- | -0.18 | -0.38 | -0.15 |
| Average Basic Shares Outstanding | -- | -- | 122.14M | 122.15M | 117.89M |
| Average Diluted Shares Outstanding | -- | -- | 122.14M | 122.15M | 117.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |